Tag Archive for US Food and Drug Administration

| April 6, 2020
No comments

FDA approves coronavirus treatment trials with Israeli drug

With the U.S. Food and Drug Administration’s approval for phase two trials, researchers are hoping that the Israeli drug Aviptadil, will be able to eliminate the so-called Acute Respiratory Distress Syndrome (ARDS), the condition responsible for the deaths of about 50% of all COVID-19 patients.

By i24NEWS

 

The U.S. Food and Drug Administration on Sunday has cleared NeuroRx, a US-Israeli pharmaceutical company, and Relief Therapeutics, a Swiss drug development company, for phase two trials for a drug that could take on a deadly condition associated with COVID-19.

The two companies announced that the FDA issued a “study may proceed” letter — which does not amount to a full-fledged drug approval — for the substance to be tried on COVID-19 patients. Continue Reading »

Category: The Diaspora | Tags: , , ,
| July 10, 2018
No comments

Israeli firm begins advanced trials for non-opioide alternative in U.S.

Headquartered in Herzliya, the Israeli pharmaceutical received the go-ahead from the FDA to commence advanced trials in the U.S. on its long-lasting pain-killer, confidant it will replace the commonly used and highly addictive opiate-based medicines.

By REUTERS

 

JERUSALEM – Israeli pharmaceuticals company PainReform has received approval from the US Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.

Many patients today dealing with pain after surgery are prescribed opioids, which can be highly addictive and are at the heart of a costly health crisis in the United States. Continue Reading »

Category: Innovations & Discoveries | Tags: , , , , ,